Daniel R. Chard - 16 Mar 2022 Form 4 Insider Report for MEDIFAST INC (MED)

Role
Chairman & CEO, Director
Signature
/s/ Jason L. Groves, attorney-in-fact
Issuer symbol
MED
Transactions as of
16 Mar 2022
Net transactions value
-$158,497
Form type
4
Filing time
21 Mar 2022, 18:57:23 UTC
Previous filing
24 Feb 2022
Next filing
11 May 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MED Common Stock Award $0 +8,509 +67% $0.000000 21,139 16 Mar 2022 Direct F1
transaction MED Common Stock Tax liability $158,497 -878 -4.2% $180.52 20,261 17 Mar 2022 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents a grant of restricted stock units issued to the reporting person under the 2012 Share Incentive Plan that will vest in three equal annual installments beginning on the first anniversary of the grant date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.